| The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer (NCT03647280) | Zhejiang Cancer Hospital | 2018-12-01 |
| The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer (NCT03756090) | Zhejiang Cancer Hospital | 2018-12-01 |
| Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer (NCT03647514) | Zhejiang Cancer Hospital | 2018-12-01 |
| A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer (NCT03280134) | Zhejiang Cancer Hospital | 2018-10-15 |
| Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis (NCT03720340) | Zhejiang Cancer Hospital | 2018-10-01 |
| A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC (NCT03678649) | Zhejiang Cancer Hospital | 2018-09-10 |
| TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients (NCT03588403) | Zhejiang Cancer Hospital | 2018-07-01 |
| The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy for Cervical Cancer (NCT05410444) | Zhejiang Cancer Hospital | 2018-07-01 |
| Individualized Pharmaceutical-care for Inpatients With Cancer Pain (NCT03455023) | Zhejiang Cancer Hospital | 2018-06-30 |
| Individualized Pharmaceutical-care in Outpatients With Cancer Pain (NCT03439904) | Zhejiang Cancer Hospital | 2018-06-30 |
| PET/MR in Locally Advanced Nasopharyngeal Carcinoma (NCT03657017) | Zhejiang Cancer Hospital | 2018-06-01 |
| A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC (NCT04543890) | Zhejiang Cancer Hospital | 2018-05-01 |
| Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma (NCT03381651) | Zhejiang Cancer Hospital | 2018-02-22 |
| Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients (NCT03411954) | Zhejiang Cancer Hospital | 2018-01-01 |
| Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer (NCT03615170) | Zhejiang Cancer Hospital | 2017-07-19 |
| Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) (NCT03213587) | Zhejiang Cancer Hospital | 2017-07-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer (NCT03175848) | Zhejiang Cancer Hospital | 2017-05-05 |
| Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions (NCT03129412) | Zhejiang Cancer Hospital | 2017-04-14 |
| Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03025958) | Zhejiang Cancer Hospital | 2017-03-13 |
| Remifemin Preventing the Climacteric Symptoms in Breast Cancer (NCT03339882) | Zhejiang Cancer Hospital | 2017-01-04 |
| Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03058432) | Zhejiang Cancer Hospital | 2017-01-01 |
| The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery (NCT06103214) | Zhejiang Cancer Hospital | 2017-01-01 |
| Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis (NCT03067753) | Zhejiang Cancer Hospital | 2016-12-01 |
| Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma (NCT03015727) | Zhejiang Cancer Hospital | 2016-12-01 |
| Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction (NCT02923128) | Zhejiang Cancer Hospital | 2016-11-01 |
| A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients (NCT02948699) | Zhejiang Cancer Hospital | 2016-11-01 |
| Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma (NCT02945878) | Zhejiang Cancer Hospital | 2016-10-01 |
| Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC) (NCT02906384) | Zhejiang Cancer Hospital | 2016-10-01 |
| Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy (NCT03647527) | Zhejiang Cancer Hospital | 2016-09-01 |
| A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma. (NCT02878889) | Zhejiang Cancer Hospital | 2016-08-01 |
| Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer (NCT03907098) | Zhejiang Cancer Hospital | 2016-06-30 |
| Whether Opioids Are Factor That Induced POD? (NCT05596071) | Zhejiang Cancer Hospital | 2016-06-25 |
| S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer (NCT02813967) | Zhejiang Cancer Hospital | 2016-06-01 |
| Acquired Resistant Mechanism of the First-generation EGFR TKIs (NCT02804217) | Zhejiang Cancer Hospital | 2016-06-01 |
| Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer (NCT02769104) | Zhejiang Cancer Hospital | 2016-05-01 |
| Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study (NCT02702323) | Zhejiang Cancer Hospital | 2016-03-01 |
| Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer (NCT03276156) | Zhejiang Cancer Hospital | 2016-02-23 |
| Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer (NCT03204734) | Zhejiang Cancer Hospital | 2016-01-01 |
| Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme (NCT02663440) | Zhejiang Cancer Hospital | 2016-01-01 |
| Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer (NCT03147963) | Zhejiang Cancer Hospital | 2015-12-20 |
| DEB-TACE Treatment in 367 Liver Cancer Patients (NCT03317483) | Zhejiang Cancer Hospital | 2015-11-12 |
| Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer (NCT02649101) | Zhejiang Cancer Hospital | 2015-10-01 |
| HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis (NCT02549911) | Zhejiang Cancer Hospital | 2015-09-01 |
| Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC (NCT02481661) | Zhejiang Cancer Hospital | 2015-07-01 |
| A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma (NCT02570893) | Zhejiang Cancer Hospital | 2015-05-01 |
| Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases (NCT02385136) | Zhejiang Cancer Hospital | 2015-04-01 |
| CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer (NCT02992067) | Zhejiang Cancer Hospital | 2015-04-01 |
| Comparable Study of Different Radiation Dose in Esophageal Carcinoma (NCT01937208) | Zhejiang Cancer Hospital | 2013-08-01 |
| Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma (NCT01915134) | Zhejiang Cancer Hospital | 2013-08-01 |
| Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer (NCT01899118) | Zhejiang Cancer Hospital | 2013-04-01 |
| Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection (NCT01926483) | Zhejiang Cancer Hospital | 2013-03-01 |
| A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep) (NCT02597868) | Zhejiang Cancer Hospital | 2013-01-01 |
| Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer (NCT01832948) | Zhejiang Cancer Hospital | 2013-01-01 |
| Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC (NCT01733589) | Zhejiang Cancer Hospital | 2012-11-01 |
| Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma (NCT01688700) | Zhejiang Cancer Hospital | 2012-09-01 |
| Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer (NCT01688713) | Zhejiang Cancer Hospital | 2012-08-01 |
| Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer (NCT01635400) | Zhejiang Cancer Hospital | 2012-06-01 |
| Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma (NCT01612286) | Zhejiang Cancer Hospital | 2012-05-01 |
| Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma (NCT01536223) | Zhejiang Cancer Hospital | 2012-04-01 |
| Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer (NCT04249440) | Zhejiang Cancer Hospital | 2012-01-01 |
| Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer (NCT01514877) | Zhejiang Cancer Hospital | 2012-01-01 |
| D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer (NCT01836991) | Zhejiang Cancer Hospital | 2012-01-01 |
| Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer (NCT01463501) | Zhejiang Cancer Hospital | 2011-10-01 |
| Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer (NCT01756183) | Zhejiang Cancer Hospital | 2011-09-01 |
| Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients (NCT01258192) | Zhejiang Cancer Hospital | 2011-01-01 |
| Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer (NCT01558947) | Zhejiang Cancer Hospital | 2011-01-01 |
| Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer (NCT01291823) | Zhejiang Cancer Hospital | 2010-12-01 |
| Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001) (NCT01158170) | Zhejiang Cancer Hospital | 2010-06-01 |
| S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer (NCT01175447) | Zhejiang Cancer Hospital | 2010-02-01 |
| S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer (NCT01175460) | Zhejiang Cancer Hospital | 2010-01-01 |
| Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (NCT01091376) | Zhejiang Cancer Hospital | 2010-01-01 |
| Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) (NCT01158144) | Zhejiang Cancer Hospital | 2009-10-01 |
| Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer (NCT04266691) | Zhejiang Cancer Hospital | 2009-01-01 |
| A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801) (NCT00886678) | Zhejiang Cancer Hospital | 2008-07-01 |
| Zoladex Plus Tamoxifen in Breast Cancer (NCT00827307) | Zhejiang Cancer Hospital | 2008-06-01 |
| A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer (NCT01731548) | Zhejiang Cancer Hospital | 2002-06-01 |